ZIKAlliance Pregnant Women Cohort

NCT03188731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3852

Last updated 2022-05-24

No results posted yet for this study

Summary

The aim of this proposal is to evaluate the causal relationship between Zika virus (ZIKV) infections in pregnancy and congenital malformations. We will estimate the absolute and relative risks of congenital malformations and other adverse outcomes of pregnancy among women who become infected with ZIKV during pregnancy compared to uninfected pregnant women, also leading to further validation of the Congenital Zika Syndrome.

Conditions

  • Zika Virus
  • Pregnancy Related

Sponsors & Collaborators

  • European Union

    collaborator OTHER
  • ZIKAlliance

    collaborator UNKNOWN
  • Oswaldo Cruz Foundation

    collaborator OTHER
  • University of Sao Paulo

    collaborator OTHER
  • London School of Hygiene and Tropical Medicine

    collaborator OTHER
  • Federal University of Bahia

    collaborator OTHER
  • Universidade Federal de Goias

    collaborator OTHER
  • University Medical Center Groningen

    collaborator OTHER
  • University of Carabobo

    collaborator OTHER
  • Universidad Industrial de Santander

    collaborator OTHER
  • Sosecali Hospital, Guyaquil

    collaborator UNKNOWN
  • Instituto de Medicina Tropical "Pedro Kourí (IPK), Cuba

    collaborator UNKNOWN
  • Mexican National Institute of Public Health

    collaborator OTHER_GOV
  • Instituto Mexicano del Seguro Social

    collaborator OTHER_GOV
  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • Erasmus Medical Center

    collaborator OTHER
  • University of Heidelberg Medical Center

    lead OTHER

Principal Investigators

  • Thomas Jänisch · University Hospital Heidelberg

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-24
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Bolivia
  • Brazil
  • Colombia
  • Cuba
  • Guadeloupe
  • Mexico
  • Venezuela

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03188731 on ClinicalTrials.gov